![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
|
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
5MB | |
![[img]](http://edoc.mdc-berlin.de/style/images/fileicons/other.png) |
Other (Supplementary Material)
438kB |
| Item Type: | Article |
|---|---|
| Title: | Serum creatinine and cystatin C-based estimates of glomerular filtration rate are misleading in acute heart failure |
| Creators Name: | Swolinsky, J.S. and Nerger, N.P. and Leistner, D.M. and Edelmann, F. and Knebel, F. and Tuvshinbat, E. and Lemke, C. and Roehle, R. and Haase, M. and Costanzo, M.R. and Rauch, G. and Mitrovic, V. and Gasanin, E. and Meier, D. and McCullough, P.A. and Eckardt, K.U. and Molitoris, B.A. and Schmidt-Ott, K.M. |
| Abstract: | AIMS: We aimed to test whether the endogenous filtration markers serum creatinine or cystatin C and equation-based estimates of glomerular filtration rate (GFR) based on these markers appropriately reflect changes of measured GFR in patients with acute heart failure. METHODS: In this prospective cohort study of 50 hospitalized acute heart failure patients undergoing decongestive therapy, we applied an intravenous visible fluorescent injectate (VFI), consisting of a low molecular weight component to measure GFR and a high molecular weight component to correct for measured plasma volume. Thirty-eight patients had two sequential GFR measurements 48 h apart. The co-primary endpoints of the study were safety of VFI and plasma stability of the high molecular weight component. A key secondary endpoint was to compare changes in measured GFR (mGFR) to changes of serum creatinine, cystatin C and estimated GFR. RESULTS: VFI-based GFR measurements were safe and consistent with plasma stability of the high molecular weight component and glomerular filtration of the low molecular weight component. Filtration marker-based point estimates of GFR, when compared with mGFR, provided only moderate correlation (Pearson's r, range 0.80-0.88, depending on equation used), precision (r(2) , range 0.65-0.78) and accuracy (56%-74% of estimates scored within 30% of mGFR). Correlations of 48-h changes GFR estimates and changes of mGFR were significant (P < 0.05) but weak (Pearson's r, range 0.35-0.39). Observed decreases of eGFR by more than 15% had a low sensitivity (range 38%-46%, depending on equation used) in detecting true worsening mGFR, defined by a >15% decrease in mGFR. CONCLUSIONS: In patients hospitalized for acute heart failure, serum creatinine- and cystatin C-based predictions performed poorly in detecting actual changes of GFR. These data challenge current clinical strategies to evaluate dynamics of kidney function in acute heart failure. |
| Keywords: | Acute Heart Failure, Worsening Kidney Function, Acute Kidney Injury, CKD-EPI Formula, Measured GFR, Visible Fluorescent Injectate |
| Source: | ESC Heart Failure |
| ISSN: | 2055-5822 |
| Publisher: | Wiley |
| Volume: | 8 |
| Number: | 4 |
| Page Range: | 3070-3081 |
| Date: | August 2021 |
| Official Publication: | https://doi.org/10.1002/ehf2.13404 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
Download Statistics
Download Statistics
